Company Innovita Biological Technology Co., Ltd.

Equities

688253

CNE100005Q14

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Diagnostic & Testing Substances

INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD.

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-21 pm EDT			5-day change	1st Jan Change
41.1 ^CNY	-1.79%		+0.20%	+64.33%

Apr. 15	Innovita Biological Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 12	China stocks track Asian markets lower on rate concerns	RE

Innovita Biological Technology Co Ltd is a China-based company mainly engaged in the research, development, production and sales of point-of-care testing (POCT) rapid diagnostic products. The Company's main products include novel coronavirus (2019-nCoV) neutralizing antibody detection kits using colloidal gold, quantum dot fluorescence immunochromatography and chemiluminescence techniques, and respiratory pathogen detection products, such as whole blood respiratory quintuple detection card, influenza virus triple detection card, virus serum quintuple detection card, respiratory pathogen nine indirect immunofluorescence kit, and others.

Number of employees: 404

CNY in Million	2022	Weight	2023	Weight	Delta
Respiratory Tract Series - Non-COVID-19 Products 84.8 %	-	-	405	84.8 %	-
Respiratory Tract Series - COVID-19 Products 12.2 %	-	-	58	12.2 %	-
Other Series 2.0 %	15	3.4 %	10	2.0 %	-35.97%
Eugenics and Nurturing Series 0.9 %	4	0.9 %	4	0.9 %	+8.31%
Point-of-care Testing Diagnostic Instrument 0.1 %	0	0.0 %	1	0.1 %	+200.00%

CNY in Million	2022	Weight	2023	Weight	Delta
China 97.3 %	421	94.3 %	465	97.3 %	+10.45%
Overseas (including Hong Kong, Macau and Taiwan) 2.7 %	26	5.7 %	13	2.7 %	-49.12%

Managers	Title	Age	Since
Xiu Jie Zhang FOU	Founder	53	06-02-05
Xiu Juan Zhao DFI	Director of Finance/CFO	50	16-09-30
Song Ling Li CHM	Chairman	43	13-09-30
Ting You Chen CTO	Chief Tech/Sci/R&D Officer	51	06-03-31
Xiao Gang Zhang BRD	Director/Board Member	60	08-08-31
Yu Heng He IRC	Investor Relations Contact	28	-
Fu Kang Chen SEC	Corporate Secretary	40	19-09-30

Members of the board	Title	Age	Since
Tian Long Hu BRD	Director/Board Member	47	20-11-08
Jian Sun BRD	Director/Board Member	42	20-11-08
Guan Mu Dong BRD	Director/Board Member	72	20-11-08
Feng Guang Ye CHM	Chairman	39	15-10-31
Xiu Jie Zhang FOU	Founder	53	06-02-05
Xiao Gang Zhang BRD	Director/Board Member	60	08-08-31
Song Ling Li CHM	Chairman	43	13-09-30
Xiu Juan Zhao DFI	Director of Finance/CFO	50	16-09-30
Hong Shuang Zhao BRD	Director/Board Member	41	23-05-31
Wen Hui Hu BRD	Director/Board Member	50	Nov. 29

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	136,060,816	50,125,833 ( 36.84 %)	0	36.84 %

Name	Equities	%	Valuation
China Asset Management Co., Ltd. 5.019 %	1,499,845	5.019 %	8 M ¥
Rongtong Fund Management Co., Ltd. 2.022 %	604,136	2.022 %	3 M ¥
CCB Principal Asset Management Co., Ltd. 1.203 %	359,330	1.203 %	2 M ¥
Hui'an Fund Management Co. Ltd. 0.7898 %	236,000	0.7898 %	1 M ¥
Maxwealth Fund Management Co., Ltd. 0.6057 %	181,000	0.6057 %	908 063 ¥
Bosera Asset Management Co., Ltd. 0.3563 %	106,479	0.3563 %	534 197 ¥
China Merchants Fund Management Co., Ltd. 0.1428 %	42,682	0.1428 %	214 132 ¥
Essence Fund Co., Ltd. 0.0790 %	23,608	0.0790 %	118 439 ¥
Tian Hong Asset Management Co., Ltd. 0.0455 %	13,600	0.0455 %	68 230 ¥
Caitong Fund Management Co., Ltd. 0.0394 %	11,764	0.0394 %	59 019 ¥

Innovita Biological Technology Co., Ltd.

1/F-2/F, Building 6 1 Haiying Road

100071, Beijing

http://www.innovita.com.cn

address Innovita Biological Technology Co., Ltd.(688253)

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD.	+64.33%	772M
BIOMÉRIEUX	-6.16%	12.09B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-3.26%	8.21B
DIASORIN S.P.A.	+6.61%	5.74B
LANTHEUS HOLDINGS, INC.	+31.20%	5.64B
AUTOBIO DIAGNOSTICS CO., LTD.	-9.05%	4.16B
10X GENOMICS, INC.	-56.99%	2.88B
ANDON HEALTH CO., LTD.	+11.87%	2.69B
VITROLIFE AB	-5.34%	2.33B
MYRIAD GENETICS, INC.	+25.34%	2.17B

Diagnostic & Testing Substances